.svg)
Supporting recruitment for a rare oncology study in Germany
Situation
A biotechnology company running an early-phase clinical study in rare oncology in Germany faced challenging recruitment, driven by highly restrictive eligibility criteria within an already limited patient subpopulation.
Objective
Build a compliant, patient-friendly recruitment pathway for a rare oncology study recruiting in Germany, enabling early identification of potentially eligible patients, structured pre-screening, and efficient referral to investigational sites.
Our Solution
Outcomes and Impact
We embraced admedicum’s services only by the time that we became aware that the inclusion of patients was not as expected due to the very restrictive nature of the eligibility criteria. The admedicum team’s experience and creativity
towards a fruitful approach to our reality of clinical study conduct within Germany clearly translated in a gateway towards potentially eligible patients, whom, upon a triage, could ultimately be guided in contacting the investigational sites.
Chief Medical Officer
Conclusion
admedicum addresses recruitment challenges in complex indications through compliant patient outreach, digital pre-screening, and structured site referral. This approach accelerates patient identification, enhances recruitment efficiency, and reduces workload for investigational sites.
Related Case Studies
